Theriva Biologics, Inc.
Datakwaliteit: 83%
TOVX
NYSE
Manufacturing
Chemicals
€ 0,24
▼
€ 0,06
(-19,19%)
Marktkapitalisatie: 11,01 M
Prijs
€ 0,24
Marktkapitalisatie
11,01 M
Dagbereik
€ 0,24 — € 0,28
52-Weeksbereik
€ 0,16 — € 1,50
Volume
4.767.400
Openen € 0,28
50D / 200D Gem.
€ 0,20
23,08% above
50D / 200D Gem.
€ 0,31
23,69% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -16,70 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-273,48%
Onder sectorgemiddelde (-53,41%)
ROIC-87,82%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio0,90
Interest Coverage-394,28
Waardering
PE (TTM)
-0,46
Boven sectorgemiddelde (-1,48)
P/B Ratio1,63
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -0,5 | -1,5 |
| P/B | 1,6 | 1,6 |
| ROE % | -273,5 | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -23,74 M |
| ROE | -273,48% | ROA | -71,22% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -16,70 M |
| ROIC | -87,82% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,90 |
| Interest Coverage | -394,28 | Asset Turnover | N/A |
| Working Capital | -1,10 M | Tangible Book Value | -12,88 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0,46 | Forward P/E | N/A |
| P/B Ratio | 1,63 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -151,66% | ||
| Market Cap | 11,01 M | Enterprise Value | 3,49 M |
| Per Share | |||
| EPS (Diluted TTM) | -2,08 | Revenue / Share | N/A |
| FCF / Share | -0,36 | OCF / Share | -0,36 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 70,37% |
| SBC-Adj. FCF | -17,38 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -23,74 M | -25,65 M | -18,35 M | -19,69 M | -14,27 M |
| EPS (Diluted) | -2,08 | -19,03 | -1,14 | -1,31 | -0,19 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -24,05 M | -26,35 M | -21,43 M | -21,58 M | -14,27 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 8,60 M | 12,03 M | 14,31 M | 11,72 M | 7,80 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 108.000,0 | 137.000,0 | 135.000,0 | 85.000,0 | 87.000,0 |
| Interest Expense | 61.000,0 | — | — | — | — |
| Income Tax | — | 0,0 | -1,64 M | -1,43 M | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 38,24 M | 35,35 M | 55,22 M | 71,86 M | 70,37 M |
| Total Liabilities | 22,86 M | 16,29 M | 15,52 M | 17,30 M | 4,96 M |
| Shareholders' Equity | 15,38 M | 19,07 M | 36,96 M | 56,39 M | 65,41 M |
| Total Debt | 1,67 M | 92.000,0 | 225.000,0 | 278.000,0 | — |
| Cash & Equivalents | 13,06 M | 11,61 M | 23,18 M | 41,79 M | 67,33 M |
| Current Assets | 17,47 M | 16,28 M | 27,40 M | 45,52 M | 68,86 M |
| Current Liabilities | 10,01 M | 7,59 M | 6,74 M | 7,06 M | 3,55 M |
{"event":"ticker_viewed","properties":{"ticker":"TOVX","listing_kind":"stock","pathname":"/stocks/tovx","exchange":"NYSE","country":"US"}}